头颈部大汗腺癌的诊断与治疗:系统综述
93.5%患者接受手术切除,41.3%出现复发,末次随访(平均55.0个月)时76.1%存活。
要点
- 头皮和眼睑持续或不典型病变应早期活检以明确诊断
- 广泛局部切除是主要治疗手段,常需复杂重建
- 高危或复发患者可考虑辅助放疗或全身治疗
核心结论
- 头颈部大汗腺癌侵袭性强但认识不足,复发风险高。
- 早期活检不典型或持续的眼睑或头皮病变对诊断至关重要。
- 广泛局部切除仍是主要治疗,高危或复发疾病可考虑辅助放疗或全身治疗。
研究设计与样本
- 按PRISMA指南进行的系统综述,检索PubMed、Embase和CINAHL数据库从建库至2025年3月。
- 使用ROBINS-I评估偏倚风险。
主要发现
- 平均年龄60.1岁,73.9%为男性。
- 肿瘤最常见于头皮(34.8%)和眼睑(30.4%),34.8%的病例报告诊断延迟。
- 93.5%患者接受手术切除,常需局部组织方法、皮肤移植和游离组织移植等复杂重建。
- 28.3%接受辅助放疗,17.4%接受化疗。
- 41.3%患者出现复发,末次随访(平均55.0个月)时76.1%存活。
临床怎么用
- 对不典型或持续的眼睑或头皮病变应早期活检以明确诊断。
- 广泛局部切除作为主要治疗,并根据缺损情况选择复杂重建。
- 高危或复发疾病可考虑辅助放疗或全身治疗。
局限性
- 因肿瘤罕见,治疗建议主要基于孤立病例报告。
- 需要更大规模的多机构数据集来明确最佳管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Apocrine carcinoma is a rare malignancy of apocrine sweat glands that can arise in the head and neck. These lesions frequently resemble benign adnexal processes, which may contribute to diagnostic delay. Owing to the rarity of this tumor, treatment recommendations are based largely on isolated case reports. METHODS: A systematic review was performed according to the PRISMA guidelines. PubMed, Embase, and CINAHL databases were queried from inception through March 2025. Studies were included if they reported at least one case of head and neck apocrine carcinoma with demographic, treatment, and outcome data. Risk of bias was assessed using ROBINS-I. RESULTS: Thirty-five studies reporting 46 patients met the inclusion criteria. Mean age was 60.1 years; 73.9% were men. Tumors most commonly arose in the scalp (34.8%) and eyelid (30.4%). Diagnostic delay was reported in 34.8% of the cases. Surgical excision was performed in 93.5% of patients, often requiring complex reconstruction including local tissue methods, skin grafting, and free tissue transfer. Adjuvant radiotherapy was administered in 28.3% and chemotherapy in 17.4% of patients. Recurrence occurred in 41.3% of patients. At the last reported follow-up (mean 55.0 months), 76.1% of patients were alive. CONCLUSIONS: Head and neck apocrine carcinoma is an aggressive but poorly recognized neoplasm that carries substantial risk of recurrence. Early biopsy of atypical or persistent eyelid or scalp lesions is critical for diagnosis. Wide local excision remains the primary treatment, and adjuvant radiotherapy or systemic therapy may be considered for high-risk or recurrent disease. Larger multi-institutional datasets are needed to define optimal management.
引用
- Jungbauer WN, Stearns HD, Diez-Montiel A, et al. Diagnosis and treatment of apocrine carcinoma of the head and neck: A systematic review. J Plast Reconstr Aesthet Surg. 2026. PMID: 41795571. doi:10.1016/j.bjps.2026.02.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。